All the major companies in the industry are constantly growing and making exciting changes and innovations. This week even more news from Tetra, Harvest One, Canopy Growth, as well as federally licensed WeedMD. Continue reading “Weekly Roundup – Sweetgrass partners up with Canopy, WeedMD announces 610K greenhouse, and more!”
Mettrum is a licensed producer of medical cannabis in Canada and is now part of Canopy growth following the $430M deal between the two companies. Mettrum has been licensed for over seven years, with its first in November 2013. Learn more about the company’s management, facilities, products and more!
The human body is one of the most amazing organisms in nature, due to its ability to learn and adapt to its environment. Unfortunately, this comes with certain drawbacks. For instance, when you go through a traumatic event, the body and mind react as to try to protect you, but can be detrimental to your mental health. Post traumatic stress disorder (PTSD) is just that and luckily, medical cannabis has proved to help. Continue reading “Cannabis and Post Traumatic Syndrome Disorder (PTSD)”
In this week’s roundup PUF Ventures brings more news about its new facility announced last week, Aurora has proposed to acquire CanniMed, Tetra’s product release is successful, and so much more. Continue reading “Weekly Roundup – PUF Ventures, Aurora, CanniMed and more!”
Established in 2013, Abba Medix Group Inc. is a wholly-owned subsidiary of Canada House Wellness Group Inc., with a license to cultivate medical marijuana from Health Canada under Access to Cannabis for Medical Purposes (ACMPR). Canada House Wellness Group Inc. was founded on September 29, 1982, and is listed on the Canadian Securities Exchange.
Continue reading “Company Overview: Abba Medix”
HIV or human immunodeficiency virus is basically an asymptomatic pathogen that causes AIDS and impedes the body’s capabilities to fight illnesses. Growing research is now showing that cannabis can help patients manage some of its devastating symptoms, and may even help in slowing the development of the virus. Continue reading “How Medical Marijuana can help with HIV/AIDS”
Multiple sclerosis (MS) is a disease that attacks the central nervous system. In the United States alone, 200 people are diagnosed with MS every week. The condition causes the body’s own immune system to attack and causes the brain and the rest of your body to lose optimum communication capabilities. As it progresses, MS keeps destroying the nerves, sometimes until they are damaged permanently. MS is recognized as a qualifying condition for accessing treatment from medical marijuana in both the US and Canada. Continue reading “How Marijuana Helps with Multiple Sclerosis (MS)”
Its only been a week and major things have already happened in the cannabis world since last week’s roundup. Continue reading “Weekly Roundup – Manitoba Announces Framework, Medreleaf and more”
For the sixth volume of our Licensed Producer series, we take a deep dive in ABCann Global, the owner of ABcann Medicinals (ABcann), a Canadian licensed producer. First licensed in early 2014, the company operates a 14,000 square foot facility in Napanee Ontario, with plans for expansions. Continue reading “Company Overview: ABcann Medicinals”
Hepatitis C is a viral infection impacting the liver, the human body’s natural filter. People who have been diagnosed with hepatitis C (HVC) normally undergo treatment using various anti-viral drugs such as Ribavirin and Peg-interferon. These treatments come with various side effects such as low appetite, aches, pains, and nausea. Various studies now show that marijuana can be effective in treating these side effects, as well as help patients, stay on their medication, hence increasing the chances of fighting the disease successfully. Continue reading “How it Helps: Cannabis and Hepatitis C”